Express-evaluation of the psycho-physiological condition of Paralympic athletes
Authors Drozdovski A, Gromova I, Korotkov K, Shelkov O, Akinnagbe F
Received 12 July 2012
Accepted for publication 19 October 2012
Published 5 December 2012 Volume 2012:3 Pages 215—222
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Alexander Drozdovski,1 Irina Gromova,2 Konstantin Korotkov,1 Oleg Shelkov,1 Femi Akinnagbe3
1Saint Petersburg Federal Research Institute of Physical Culture and Sport, St Petersburg, Russia; 2Paralympic Team of Russia, Moscow, Russia; 3Georgetown University, Washington, DC, USA
Objective: Evaluation of elite athletes’ psycho-physiological condition at various stages of preparation and in international competition.
Design: Athletes were tested during training and participation in international competition using methods of galvanic skin response (GSR) and gas discharge visualization (GDV).
Setting: Saint Petersburg Federal Research Institute of Physical Culture and Sport, Russia and Paralympic athletic training camp, Norway.
Participants: Eighteen athletes from Russia’s Skiing and Biathlon Paralympic Team. All athletes had some level of damage to their musculoskeletal system.
Main outcome measures: Stress level (SL), energy potential (EP), and psycho-emotional tension (PET).
Results: It was found that the higher the level of EP achieved by the athlete in the training period, the lower the SL in the competition time. The SL of an athlete recorded in the training period significantly correlates with the SL both before and at the time of competition. The PET and SL before the World Cup was negatively correlated to the results of skiing competitions.
Conclusion: Evaluation of PET, EP, and SL through GSR and GDV offers a fast, highly precise, non-invasive method to assess an athlete’s level of readiness during both training and at the time of competition.
Keywords: paralympic sport, express-analysis, galvanic skin response (GSR), gas discharge visualization (GDV)
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
Kannicht C, Kohla G, Tiemeyer M, Walter O, Sandberg H
Published Date: 23 July 2015
Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people
Denison HJ, Cooper C, Sayer AA, Robinson SM
Published Date: 11 May 2015
Published Date: 12 December 2014
Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries
Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M
Published Date: 12 December 2014
Published Date: 22 July 2014
Khair K, Holland M
Published Date: 6 May 2014
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
Lentz SR, Tandra A, Gut RZ, Cooper DL
Published Date: 13 January 2014
Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation
Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K
Published Date: 5 December 2012
Tuohy E, Litt E, Alikhan R
Published Date: 20 April 2011
The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al
Published Date: 6 August 2010